Value of Follicular Flushing. Randomised Controlled Trial

March 29, 2023 updated by: Eugonia

Does Addition of Follicular Flushing to the Initial Aspiration Lead to Higher Numbers of Oocytes Retrieved in Women Undergoing Oocyte Retrieval? A Randomized Controlled Trial

The purpose of this study is to evaluate whether the addition of follicular flushing to the initial aspiration during oocyte retrieval increases the number of oocytes retrieved in women undergoing ovarian stimulation.

Study Overview

Detailed Description

There is an ongoing debate regarding the effectiveness of follicular flushing during oocyte retrieval. Currently published studies and metanalyses suggest that follicular flushing does not improve live birth rate, clinical pregnancy rate or the number of oocytes retrieved. However, currently published studies may be confounded by the types of needle used, aspiration pressures, number of times flushing is repeated, etc. Additionally, follicular flushing should be examined in specific patient populations according to their response to ovarian stimulation.

In the current study, each woman will have one ovary (right or left) randomly assigned to be aspirated with or without the addition of follicular flushing. This study design ensures that clinical and demographic characteristics of the couple will not affect the outcomes evaluated. The primary endpoints will be the number of oocytes retrieved per ovary assigned to each group. Secondary outcomes will be the oocyte recovery rate (oocytes retrieved per follicle aspirated) oocyte maturation rate, fertilization rate, and embryo development per ovary assigned to each group.

The study population will include three subgroups according to observed ovarian response to ovarian stimulation (poor responders, normal responders, hyper responders). Assuming a minimum clinically significant difference in oocyte yield of 1 oocyte, a sample size of twenty patients per subgroup is required to yield 80% power.

Patients aged <43 years with the presence of at least one follicles >11mm in each ovary on the day of triggering final oocyte maturation will be eligible for inclusion in the study. 60 patients (20 in each of the aforementioned subgroup) will be recruited and just prior to oocyte retrieval their left and right ovaries will be randomly allocated into flushing or the no-flushing group. In both ovaries all follicles greater than 11mm will be punctured by the same 16G double lumen needle, using the same aspiration pressure. In the flushing group, flushing will be performed up to a maximum of five times or until a cumulus oocyte complex (COC) is retrieved.

In the control group all follicles greater than 11mm will be aspirated by the same double lumen needle and no flushing will be performed.

All COCs will be grouped according to the ovary they originated from by the embryologists and their development will be recorded until Day 3 following fertilization (Number of MII oocytes, number of fertilized oocytes, number good quality Day 3 embryos).

Study Type

Interventional

Enrollment (Actual)

105

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: George T Lainas, PhD
  • Phone Number: +302107236333
  • Email: ggslns@gmail.com

Study Locations

      • Athens, Greece, 11528
        • Eugonia Unit of Assisted Reproduction

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 43 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Presence of both ovaries
  • 18-43 years old
  • At least one follicle >11mm present in each ovary on day of triggering final oocyte maturation.

Exclusion Criteria:

  • Ovarian surgery
  • Monofolicular development

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Follicular aspiration with addition of follicular flushing.
All follicles will be aspirated with the addition of follicular flushing if necessary (up to 5 times per follicle)
Follicular flushing if necessary up to 5 times using a double lumen needle for oocyte recovery
No Intervention: Follicular aspiration only.
All follicles will be aspirated and no flushing will be applied.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of oocytes retrieved
Time Frame: During oocyte collection (usually 10-30 minutes)
Number of oocytes retrieved per ovary randomised
During oocyte collection (usually 10-30 minutes)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Oocyte recovery rate
Time Frame: During oocyte collection (usually 10-30 minutes)
Number of oocytes retrieved per follicle aspirated
During oocyte collection (usually 10-30 minutes)
Oocyte maturation rate
Time Frame: During oocyte denudation (usually 10-30 minutes)
Number of mature (metaphase-II) oocytes divided by the number of oocytes retrieved per ovary randomised
During oocyte denudation (usually 10-30 minutes)
Fertilization rate
Time Frame: During fertilisation check (usually 10 minutes)
Number of fertilised (2PN) oocytes divided by the number of matured oocytes retrieved per ovary randomised
During fertilisation check (usually 10 minutes)
Percentage of good quality embryos on day 2/3
Time Frame: During embryo evaluation (usually 10 minutes)
Number of good quality embryos divided by the number of fertilized oocytes per ovary randomised
During embryo evaluation (usually 10 minutes)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 15, 2022

Primary Completion (Actual)

December 30, 2022

Study Completion (Actual)

December 31, 2022

Study Registration Dates

First Submitted

July 15, 2022

First Submitted That Met QC Criteria

July 21, 2022

First Posted (Actual)

July 26, 2022

Study Record Updates

Last Update Posted (Actual)

March 30, 2023

Last Update Submitted That Met QC Criteria

March 29, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Flushing RCT

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on Experimental: Follicular aspiration with addition of follicular flushing.

3
Subscribe